These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Neurotransmitter interactions related to central dopamine neurons. Lloyd KG. Essays Neurochem Neuropharmacol; 1978; 3():129-207. PubMed ID: 30628 [No Abstract] [Full Text] [Related]
4. Changes in the sensitivity of receptors for neurotransmitters and the actions of some psychotherapeutic drugs. Richelson E, El-Fakahany E. Mayo Clin Proc; 1982 Sep; 57(9):576-82. PubMed ID: 6125630 [Abstract] [Full Text] [Related]
6. Neuroleptic-induced supersensitivity psychosis, the "hump course," and tardive dyskinesia. Chovinard G, Jones B. J Clin Psychopharmacol; 1982 Apr; 2(2):143-4. PubMed ID: 6122695 [No Abstract] [Full Text] [Related]
7. [The mediator, receptor and messenger2 system in medicine]. Filip V. Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1985 Apr; 37(1):7-18. PubMed ID: 2861639 [No Abstract] [Full Text] [Related]
8. Adaptive responses of brain cyclic AMP-generating systems to alterations in synaptic input. Dismukes RK, Daly JW. J Cyclic Nucleotide Res; 1976 Apr; 2(5):321-36. PubMed ID: 12192 [Abstract] [Full Text] [Related]
9. Neural pathways and neurotransmitters affecting melatonin synthesis. Ebadi M, Govitrapong P. J Neural Transm Suppl; 1986 Apr; 21():125-55. PubMed ID: 2875124 [Abstract] [Full Text] [Related]
10. Cerebral monoamine neurotransmitters in opioid withdrawal and dependence. Ahtee L, Attila LM. Med Biol; 1987 Apr; 65(2-3):113-9. PubMed ID: 2888928 [Abstract] [Full Text] [Related]
11. [Significance of brain nondopaminergic mechanisms for the specific action and side effects of neuroleptics]. Arushanian EB. Farmakol Toksikol; 1983 Apr; 46(1):99-107. PubMed ID: 6130975 [No Abstract] [Full Text] [Related]